knowledge -WSS

knowledge

author：entertainment 2025-09-27 10:27:09 - browse：791

Sage Therapeutics, a biotech developing an experimental treatment for postpartum depression, this week trumpeted strong results from a clinical trial, which cheered investors and pushed up its stock price. But outside the lab, the company’s aggressive efforts to raise awareness of postpartum depression have proved divisive.

The campaign’s message: “When it comes to postpartum depression, silence sucks.” It features close-up photos of distressed, tearful women who can’t speak — because they have pacifiers stuck in their mouths.

The images have been plastered on bus stops, buses, conference booths, and on a dedicated website. The ads don’t specifically mention Sage’s drug, which still needs further testing before the company can bring it to the Food and Drug Administration for possible approval. Instead, they urge women to talk “openly and honestly” about postpartum depression. An estimated 600,000 women in the U.S. alone experience symptoms, which range from insomnia and irritability to difficulty bonding with their baby.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： New lesbian bars spark hope amid disappearing LGBTQ+ spaces

focus

explore

WSS

Judge sides with young activists in first

Be careful with at

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

Maui wildfire now ranks as the fifth

What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

Federal board approves $12.7 billion budget for Puerto Rico as island shakes off bankruptcy

hotspot

knowledge

focus

Continuity nursing helped my family in our darkest PICU moments

Tuskegee Airman Raymond Cassagnol dies at 102

Novavax promises a turnaround & Lilly roils the obesity market

Medical experts exlpore how to eliminate bias in clinical algorithms

23andMe had bad news about my health. I wish a person had delivered it

BMS, looking to build heart drug business, turns to AI for diagnosis

After affirmative action ruling, medical educators look to 'holistic review'

Here's how to stay safe from wildfire smoke amid reduced air quality

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Why do we get seasonal allergies?

focus

Hospitals are dialing back on venture capital investing

UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

Aspartame and sugar

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

Medical experts exlpore how to eliminate bias in clinical algorithms

focus

Wikipedia

explore

focus